Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557)
Guardado en:
| Udgivet i: | Alzheimer's & Dementia vol. 21 (Dec 1, 2025) |
|---|---|
| Hovedforfatter: | |
| Andre forfattere: | , , |
| Udgivet: |
John Wiley & Sons, Inc.
|
| Fag: | |
| Online adgang: | Citation/Abstract Full Text - PDF |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
Vær først til at give en kommentarø!